Hypothesis
prion," or molecule that specifies prion infectivity). These alternative theories are maintained even though, as with the miasma, no one has ever demonstrated the Much like the "microbe hypothesis" put forth over presence of these agents. It is demanded that the prion 150 years ago, the "prion hypothesis" can be defihypothesis satisfy the prion version of the Koch's posnitely proven only if a prion disease is engendered in tulate: the original disease must be reproduced in a a natural host from an infectious prion produced recipient from prions grown and purified in vitro after in vitro. In this issue of Cell, Castilla et al. (2005) (Magner, 1992) . By that time, a set of criteria known as "Koch's postulates" had to be satisever, a major caveat of this remarkable work is that the disease could only be engendered in transgenic mice fied to prove the microbe hypothesis. The original disease had to be reproduced from microbes that were overexpressing the truncated PrP at 16 times the normal level of PrP C and only after a long incubation time. cultured and purified in vitro, after being obtained from the infected individual.
Thus, several investigators have questioned whether the in vitro-generated PrP fragment is indeed "infecHistory is repeating itself with prions. Prion diseases or transmissible spongiform encephatious" or simply acts by precipitating an existing condition that is already programmed genetically. lopathies affect humans and animals. Although prion diseases have an incidence of only one case per milIn this issue of Cell, Castilla and coworkers took a different approach in an attempt to provide incontrolion, they pose a considerable threat to public health because, unlike neurodegenerative diseases, they are vertible proof of the prion hypothesis. These investigators had previously improved the efficiency of an transmissible not only between humans but also to humans from animals where they are endemic in several in vitro PrP C to PrP Sc conversion system, originally introduced by Caughey and collaborators (Kocisko et al., species. The lack of inflammatory reaction characteristic of infectious diseases, the long incubation time, and 1994). A fundamental problem with the Caughey in vitro conversion method is that the newly formed PrP Sc rethe resistance of the infectivity to radiation that destroys living microorganisms clearly set prion diseases mains below the level of the template PrP Sc and cannot be proven to be infectious. A simple but critical feature apart from other infectious diseases. These factors led to the hypothesis that the infectious agent of these disin the improved procedure is the addition of a sonication step between cycles of PrP C to PrP Sc conversion eases, later called prion, was not a living organism but a protein (Griffith, 1967; Prusiner, 1982 ring infectivity and specificity to the new PrP Sc . This notwithstanding, the PMCA system offers golden opportunities to further investigate PrP C to PrP Sc conversion. It already indicates that the seeding mechanism (Jarrett and Lansbury, 1993) is more likely to be operational in PrP C to PrP Sc conversion than the "refolding" mechanism (Griffith, 1967; Prusiner, 1991) (Figure 1) . The robustness of the PMCA system provides the opportunity to study conversion analytically and mechanistically, for example by starting from a recombinant prion and testing individually the molecules that may be required for an efficient conversion. This is likely to be accomplished in the near future.
The prion hypothesis will then be finally and irrefutably proven, and, in a few years, we may look at it in the same way we now look at the contagia animata hypothesis, wondering how something so obvious could elicit so much controversy. 
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